Similar drugsTo uncover
Dosage form: & nbsppills
Composition:

Active substance:

Beta-alanine 400 mg.

Auxiliary substances:

Magnesium stearate 8.0 mg.

Glycerol palmityl stearate is 31.2 mg.

Hydrated silicon 36 mg.

Wheat starch 304,80 mg.

Description:Ploskotsilindrichesky white tablets.
Pharmacotherapeutic group:Anti-climacteric
ATX: & nbsp
  • Other drugs for use in gynecology
  • Pharmacodynamics:

    Beta-alanine is an amino acid. Counteracts the rapid release of histamine, but does not have antihistaminic activity due to the absence of blockade of HI-receptors.

    Beta-alanine has a direct effect on cutaneous peripheral vasodilation, which causes vegetative "hot flashes", a feeling of heat, heat, a headache. At the physiological level, vasomotor "hot flashes" are caused by the activity of thermoregulatory centers in the hypothalamus, leading to peripheral cutaneous vasodilation. This is a consequence of the reactions that occur when the balance of cerebral neurotransmitters is violated, which occurs after the cessation of the secretion of hormones by the ovaries. The drug helps saturate the peripheral receptors of neurotransmitters, which are involved in this process.

    Indications:"Tides" in the period of menopause.
    Contraindications:

    Hypersensitivity to the components of the drug.

    Hypersensitivity or intolerance to gluten (due to the presence of wheat starch in the composition).

    Dosing and Administration:

    The drug is used inside.

    1-2 tablets daily. The dose can be increased to 3 tablets per day. Duration of treatment - from 5-10 days until the disappearance of "tides". When you resume symptoms, you should re-treat.

    Side effects:Very rarely: skin allergic reactions (itching, rash). Very rarely: transient paresthesia, usually in the limbs.
    Overdose:

    Cases of drug overdose are not registered.

    In case of an overdose of the drug, symptomatic therapy should be performed.

    Interaction:Clinically significant drug interactions with other drugs have not been identified.
    Special instructions:There is no addiction to the drug, the course of treatment can be prescribed throughout the period of vasomotor clinical disorders.
    Effect on the ability to drive transp. cf. and fur:There is no evidence of a negative effect of the drug on the ability to drive and other vehicles.
    Form release / dosage:
    Tablets 400 mg.
    Packaging:

    10 tablets in a blister (PVC - aluminum), 3 blisters are placed in a cardboard box together with instructions for use.

    15 tablets in a blister (PVC - aluminum), 2 blisters are placed in a cardboard box together with instructions for use.

    Storage conditions:

    Store at a temperature not exceeding 25 ° C.

    Keep out of the reach of children.

    Shelf life:

    3 years.

    Do not use after expiry date.

    Terms of leave from pharmacies:Without recipe
    Registration number:LS-002630
    Date of registration:26.10.2011 / 19.08.2016
    Expiration Date:Unlimited
    The owner of the registration certificate:Bouchard-Recordati LaboratoriesBouchard-Recordati Laboratories France
    Manufacturer: & nbsp
    Representation: & nbspRUSFIK LLC RUSFIK LLC Russia
    Information update date: & nbsp12.01.2018
    Illustrated instructions
      Instructions
      Up